Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Nigeria warns its citizens in South Africa to be cautious after march turns violent - 2Computerized Strengthening d: A Survey of \Upgrading Efficiency\ Programming Application
- 3Culinary Joys: Investigating Connoisseur Cooking at Home
- 4Schools to start reopening after Nigeria mass abduction
- 5Figure out how to Use Your Brain research Degree in the Gig Market
- Dark matter obeys gravity after all — could that rule out a 5th fundamental force in the universe?
- Europe picks companies to help build Argonaut moon lander
- Excelling at Discussion: Genuine Examples of overcoming adversity
- Ergonomic Office Seats for Work spaces
- One third of Spanish pork export certificates blocked since swine fever outbreak, minister says
- New materials, old physics – the science behind how your winter jacket keeps you warm
- Indonesian Mega-Farm Drives Surge in Deforestation
- NASA's Artemis 2 moon launch may be visible from Florida and southern Georgia today. Here's when to look
- SpaceX shatters its rocket launch record yet again — 165 orbital flights in 2025
